VIRAGENESIS | Timeline of Parental Epimutations Mapping Table

Document Type: VIRAGENESIS R&D

Timeline Mapping

VIRAGENESIS Stage	Parental Epimutation Category	Mechanistic Interaction with ERV Reactivation	Preventive Strategies	Corrective / Restorative Strategies
Pre-Conception (Parental Germline Priming)	Germline DNA methylation loss (toxin exposure, malnutrition, stress)	Reduces ERV silencing prior to fertilization → increases baseline ERV accessibility	• Toxin avoidance (pesticides, heavy metals, endocrine disruptors)	• Micronutrient optimization (folate, B12, choline, betaine) • Antioxidant support • Pre-conception detox protocols • Targeted epigenetic re-silencing agents (DNMT stabilizers, HDAC modulators)
Gamete Maturation Phase	Histone modification drift in sperm/oocytes	Alters chromatin packaging at ERV loci → primes for early zygotic activation	• Circadian rhythm alignment	• Endocrine disruptor avoidance (plastics, BPA) • Assisted reproduction with epigenetic screening • Gamete selection and conditioning protocols
Fertilization & Early Zygotic Genome Activation	Parental ncRNA transmission (piRNA, miRNA dysregulation)	Disrupts small RNA-mediated ERV repression during first cell divisions	• Maternal diet rich in RNA-modulating phytonutrients (flavonoids, polyphenols)	• RNA therapy candidates to restore regulatory RNA pools • Synthetic piRNA/miRNA mimics
Implantation & Early Embryogenesis	Imprinted gene methylation defects (inherited or induced)	Cross-talk between imprinted loci and ERV regulatory regions → early immune mimicry	• Controlled maternal inflammation	• Progesterone optimization • Epigenome editing tools to correct imprinting errors • Precision methylation modifiers
Fetal Organogenesis	TE derepression susceptibility (heterochromatin instability)	Spreading heterochromatin loss from parental epimutations → ERV derepression	• Maternal nutrient sufficiency (folate, methionine, zinc)	• Stress minimization • Pharmacological TE repressors in high-risk pregnancies • Small-molecule chromatin stabilizers
Postnatal Development (Infant)	Altered parental histone variant deposition (H3.3, macroH2A)	Establishes long-term ERV chromatin states → affects immune training & tolerance	• Breastfeeding (maternal microbiome/epigenome benefits)	• Low-toxin environment • Pediatric epigenetic dietary support • Microbiome restoration therapy
Puberty & Early Adulthood	Secondary epimutations via mitochondrial DNA methylation drift (parental inheritance)	Alters nuclear–mitochondrial cross-talk → enhances ERV reactivation under stress	• Lifestyle-based mitochondrial support (exercise, fasting, redox balance)	• Targeted mitotherapy • Redox stabilizers (CoQ10, NAD⁺ boosters)

Key Notes

Tier 0 placement: Parental epimutations act as ever-present primers at conception.
Fault amplification: They lower the ERV activation threshold, making subsequent environmental triggers more pathogenic.
Preventive leverage: The largest intervention window exists pre-conception and during early germline/zygote phases.
Restorative leverage: Later phases demand higher-intensity interventions such as epigenome editing, small RNA therapy, or mitochondrial reset protocols.

Timeline Mapping

VIRAGENESIS Stage	Parental Epimutation Category	Mechanistic Interaction with ERV Reactivation	Preventive Strategies	Corrective / Restorative Strategies
Pre-Conception (Parental Germline Priming)	Germline DNA methylation loss (toxin exposure, malnutrition, stress)	Reduces ERV silencing prior to fertilization → increases baseline ERV accessibility	• Toxin avoidance (pesticides, heavy metals, endocrine disruptors)	• Micronutrient optimization (folate, B12, choline, betaine) • Antioxidant support • Pre-conception detox protocols • Targeted epigenetic re-silencing agents (DNMT stabilizers, HDAC modulators)
Gamete Maturation Phase	Histone modification drift in sperm/oocytes	Alters chromatin packaging at ERV loci → primes for early zygotic activation	• Circadian rhythm alignment	• Endocrine disruptor avoidance (plastics, BPA) • Assisted reproduction with epigenetic screening • Gamete selection and conditioning protocols
Fertilization & Early Zygotic Genome Activation	Parental ncRNA transmission (piRNA, miRNA dysregulation)	Disrupts small RNA-mediated ERV repression during first cell divisions	• Maternal diet rich in RNA-modulating phytonutrients (flavonoids, polyphenols)	• RNA therapy candidates to restore regulatory RNA pools • Synthetic piRNA/miRNA mimics
Implantation & Early Embryogenesis	Imprinted gene methylation defects (inherited or induced)	Cross-talk between imprinted loci and ERV regulatory regions → early immune mimicry	• Controlled maternal inflammation	• Progesterone optimization • Epigenome editing tools to correct imprinting errors • Precision methylation modifiers
Fetal Organogenesis	TE derepression susceptibility (heterochromatin instability)	Spreading heterochromatin loss from parental epimutations → ERV derepression	• Maternal nutrient sufficiency (folate, methionine, zinc)	• Stress minimization • Pharmacological TE repressors in high-risk pregnancies • Small-molecule chromatin stabilizers
Postnatal Development (Infant)	Altered parental histone variant deposition (H3.3, macroH2A)	Establishes long-term ERV chromatin states → affects immune training & tolerance	• Breastfeeding (maternal microbiome/epigenome benefits)	• Low-toxin environment • Pediatric epigenetic dietary support • Microbiome restoration therapy
Puberty & Early Adulthood	Secondary epimutations via mitochondrial DNA methylation drift (parental inheritance)	Alters nuclear–mitochondrial cross-talk → enhances ERV reactivation under stress	• Lifestyle-based mitochondrial support (exercise, fasting, redox balance)	• Targeted mitotherapy • Redox stabilizers (CoQ10, NAD⁺ boosters)

Key Notes

Tier 0 placement: Parental epimutations act as ever-present primers at conception.

Fault amplification: They lower the ERV activation threshold, making subsequent environmental triggers more pathogenic.

Preventive leverage: The largest intervention window exists pre-conception and during early germline/zygote phases.

Restorative leverage: Later phases demand higher-intensity interventions such as epigenome editing, small RNA therapy, or mitochondrial reset protocols.